| |
| |
|
| Insider
Information: |
Mcglynn Margaret G |
| Relationship: |
Director |
| City: |
Whitehouse Station |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
63,267 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$711,473 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
63,267 |
|
|
| Total
Value |
$711,473 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
Director |
2022-05-01 |
178 |
2012-11-07 |
0 |
Premium* |
|
|
Amicus Therapeutics Inc |
FOLD |
|
2024-03-05 |
59,289 |
2015-11-10 |
0 |
Premium* |
|
|
Novavax Inc |
NVAX |
Director |
2023-06-10 |
3,800 |
2022-06-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
66 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVAX |
Novavax Inc |
Director |
– • – |
2022-06-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
700 |
700 |
0 |
- |
|
| NVAX |
Novavax Inc |
Director |
– • – |
2023-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,100 |
3,800 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2011-11-22 |
5 |
B |
$28.00 |
$868 |
D/D |
31 |
1,088 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2011-12-06 |
5 |
B |
$29.66 |
$979 |
D/D |
33 |
1,088 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2011-12-07 |
5 |
B |
$29.19 |
$263 |
D/D |
9 |
1,088 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2012-08-10 |
5 |
B |
$51.23 |
$768 |
D/D |
15 |
1,088 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2012-11-07 |
4 |
B |
$45.50 |
$45,500 |
D/D |
1,000 |
1,000 |
2.39 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2015-04-06 |
4 |
OE |
$53.85 |
$673,125 |
D/D |
12,500 |
13,588 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2015-04-06 |
4 |
AS |
$117.14 |
$1,479,523 |
D/D |
(12,500) |
1,088 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2015-06-01 |
4 |
AS |
$126.78 |
$1,591,515 |
D/D |
(12,500) |
1,088 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2015-06-01 |
4 |
OE |
$53.85 |
$690,225 |
D/D |
12,500 |
13,588 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2015-08-03 |
4 |
AS |
$136.49 |
$1,716,050 |
D/D |
(12,500) |
1,088 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2015-08-03 |
4 |
OE |
$57.27 |
$715,875 |
D/D |
12,500 |
13,588 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2015-11-18 |
4 |
AS |
$130.15 |
$1,626,875 |
D/D |
(12,500) |
1,088 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2015-11-18 |
4 |
OE |
$57.27 |
$715,875 |
D/D |
12,500 |
13,588 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2016-06-01 |
4 |
A |
$0.01 |
$29 |
D/D |
2,941 |
4,029 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2017-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,188 |
6,217 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2018-01-22 |
4 |
AS |
$160.00 |
$1,600,000 |
D/D |
(10,000) |
6,217 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2018-01-22 |
4 |
OE |
$59.55 |
$595,500 |
D/D |
10,000 |
16,217 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2018-01-23 |
4 |
AS |
$165.00 |
$1,650,000 |
D/D |
(10,000) |
6,217 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2018-01-23 |
4 |
OE |
$59.55 |
$595,500 |
D/D |
10,000 |
16,217 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2018-03-02 |
4 |
AS |
$170.00 |
$1,700,000 |
D/D |
(10,000) |
6,312 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2018-03-02 |
4 |
OE |
$81.54 |
$815,400 |
D/D |
10,000 |
16,312 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2018-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,801 |
8,113 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2018-06-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,188) |
5,925 |
0 |
- |
|
66 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
